doi:10.1007/s00134-003-2031-5 Hammarqvist F, Luo J-L, Andersson K, Wernerman J, Wernerman J
Australian Peptide supplies BPC-157 exclusively as a research material for laboratory investigation and analytical applications
The Precision Peptide Genetic Test costs $99 as an add-on after your first month of treatment
No lethal dose identified at doses up to 20 mg/kg in animal studies No organ toxicity observed across multiple organ systems Negative mutagenicity testing across standard assays No teratogenic effects in pregnancy studies Limited long-term human data beyond 6 weeks Theoretical Considerations The primary theoretical concern relates to BPC-157s angiogenic properties
And some of it looks like the drug working directly, cooling the chronic inflammation that lets cancer get a foothold, a piece that may not care what you weigh at all
New evidence from single-cell RNA sequencing (scRNA-seq) studies has helped us identify different subtypes of CAFs, mainly including myofibroblastic CAFs, antigen-presenting CAFs, and inflammatory CAFs, which have different phenotypes and functions [26]